Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.82 USD
0.33%
Market Closed
Updated:
Jun 2, 2024
Taro Pharmaceutical Industries Ltd
Net Change in Cash
|
Taro Pharmaceutical Industries Ltd
Net Change in Cash Peer Comparison
Comparables:
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Net Change in Cash
$208.4m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Net Change in Cash
$815m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Net Change in Cash
-₪131.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-48%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Net Change in Cash
-$22m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Net Change in Cash
-₪898k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Net Change in Cash
-₪2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Net Change in Cash?
Net Change in Cash
208.4m
USD
208.4m
USD
Based on the financial report for Mar 31, 2024, Taro Pharmaceutical Industries Ltd's Net Change in Cash amounts to 208.4m USD.
What is Taro Pharmaceutical Industries Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
31%
31%
The average annual Net Change in Cash growth rates for Taro Pharmaceutical Industries Ltd have been 31% over the past three years .
You don't have any saved screeners yet
